The innovation and technology leader in sinus dressings. PosiSep X BAM incorporates Hemostasis’ shellfish-free BioNOCC chitosan with two water-soluble and mobile antimicrobials to bring the next generation of sinus dressings to the ENT market.
BAM is a groundbreaking advancement in the sinus dressings market. Hemostasis first revolutionized sinus care in 2011 with the launch of PosiSep, utilizing cutting-edge chitosan technology. Since then, we have continuously pursued innovating, introducing NOCC anti-adhesion technology in 2016, along with a compressed, shape-memory wafer design that enhances ease of use and sets a new standard for sinus dressings.
Following this, we proudly introduced BioNOCC-the, the world’s first non-shellfish chitosan sinus dressing, expanding our commitment to safety and efficacy.
BAM elevates our innovative journey even further by incorporating two effective antimicrobial agents, providing protection against gram-positive and gram-negative bacteria, as well as fungi. Experience the next level of sinus dressing technology with PosiSep X BAM.
For detailed information regarding indications for use, warnings and precautions, see Instructions for Use.